Hybridoma cell strain 2C9, anti-aflatoxin M1 monoclonal antibody produced by hybridoma cell strain 2C9 and application thereof
A hybridoma cell line and aflatoxin technology, applied in the fields of application, microbiology, biochemical equipment and methods, can solve the problems of cumbersome operation, cumbersome processing, and long time consumption, and achieve high sensitivity and good specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Embodiment 1: the preparation of hybridoma cell line 2C9
[0020] 1. Animal immunization
[0021] Six 6-week-old BALB / c mice were purchased and immunized with commercially available aflatoxin M1 complete antigen AFM1-BSA. For the first immunization, the aflatoxin M1 complete antigen was emulsified with an equal amount of Freund's complete adjuvant, and then injected subcutaneously at multiple points on the back of the neck of the mouse. The second immunization was carried out 4 weeks later, and the mouse was injected intraperitoneally with Freund's incomplete adjuvant and the same amount of aflatoxin M1 complete antigen emulsification. The interval between the third immunization and the second immunization was 4 weeks, and the immunization method was the same. The fourth immunization was carried out 3 weeks after the third immunization, and the immunization method was the same as the second immunization, which was also intraperitoneal injection. The doses for the four...
Embodiment 2
[0026] Embodiment 2: Anti-aflatoxin M1 monoclonal antibody hybridoma cell line 2C9 antibody variable region sequence determination
[0027] (1) Extract total RNA: use the total RNA extraction kit from Tiangen Company and follow the instructions to extract the total RNA that can produce hybridoma cell line 2C9;
[0028] (2) cDNA synthesis: using the total RNA obtained in step 1 as a template, oligo (dT) 15 For primers, follow SuperScript TM -2 II Reverse Transcriptase Instructions for reverse transcription to synthesize the first strand of cDNA; primer oligo (dT) 15 Purchased from Invitrogen;
[0029] (3) Cloning of variable region genes by PCR method: Design primers according to the conserved sites of mouse antibody gene sequences in GENEBANK, and use cDNA as a template to amplify antibody light and heavy chain variable region genes. The PCR program was: 94°C for 30s, 55°C for 1min, 72°C for 1min, 30 cycles of amplification, and finally 72°C for 10min. After the PCR produ...
Embodiment 3
[0031] Example 3: Preparation, purification, subtype and identification of anti-aflatoxin M1 monoclonal antibody
[0032] The anti-aflatoxin M1 monoclonal antibody hybridoma cell line 2C9 obtained in Example 2 was injected into BALB / c mice that had been treated with Freund's incomplete adjuvant in advance, and the ascites of the mice was collected, and octanoic acid-ammonium sulfate was used to The antibody was purified by the method, and the specific operation was as follows: filter the mouse ascites with double-layer filter paper, centrifuge at 12000r / min for 15min at 4°C, absorb the supernatant, mix the obtained ascites supernatant with 4 times the volume of acetate buffer, and stir slowly Add n-octanoic acid, the volume of n-octanoic acid required per milliliter of ascites is 33 μL, mix at room temperature for 30 minutes, let stand at 4°C for 2 hours, then centrifuge at 12,000 r / min for 30 minutes at 4°C, discard the precipitate, and filter the obtained supernatant with dou...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
reaction rate constant | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com